Where Will CV Sciences Inc (CVSI) Stock Go Next After It Is Lower By 0.00% in a Week?

Overall market sentiment has been high on CV Sciences Inc (CVSI) stock lately. CVSI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

CV Sciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CVSI!

See Full CVSI Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With CVSI Stock Today?

CV Sciences Inc (CVSI) stock is flat -7.95% while the S&P 500 is up 0.35% as of 12:13 PM on Wednesday, Mar 27. CVSI is unmoved $0.00 from the previous closing price of $0.04 on volume of 109,767 shares. Over the past year the S&P 500 has gained 31.29% while CVSI is unmoved 0.00%. CVSI earned $0.01 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.3. To see InvestorsObserver's Sentiment Score for CV Sciences Inc click here.

More About CV Sciences Inc

CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient. Click Here to get the full Stock Report for CV Sciences Inc stock.